Plain-English translation of NCT06650852 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a combination of three medications—, BRII-835, and pegylated interferon alpha—to see if they work better together than interferon alone for people with chronic hepatitis B. You would be taking your regular antiviral medications plus either the new combination or a placebo (a dummy treatment that looks identical). The goal is to find out if this medication combination helps more people achieve long-term control of the virus.
Even with current antiviral treatments, many people with hepatitis B don't reach a cure or achieve sustained remission. This trial is exploring whether adding these experimental medications could help more patients reach better, longer-lasting outcomes.
You likely qualify if…
You likely don't qualify if…
You would receive either the new combination of medications or a placebo alongside your regular antiviral pills. The interferon is given as an injection under the skin or into muscle, likely weekly based on standard practice. You'll have clinic visits for blood tests and health checks to monitor how well the treatment is working and watch for side effects. The study will follow you for several months to evaluate whether the new medication combination helps your body control the virus better than interferon alone.
AI-generated summary from trial data · Sep 3, 2026 · Not medical advice
China